Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (0LIF.LSE) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-2.23

-1.99

-1.76

-1.52

Details

Expected EPS

-1.660679

Actual EPS

-1.52

Surprise EPS

0.14

Surprise Percent

+8.47%

Description

Ultragenyx Pharmaceutical (0LIF.LSE) has reported earnings of -1.52 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.